Forte Biosciences Inc

NASDAQ:FBRX   4:00:00 PM EDT
0.98
-0.03 (-2.97%)
Earnings Announcements

Forte Biosciences Inc. Announces Third Quarter 2022 Results, Provides Business Update

Published: 11/14/2022 21:11 GMT
Forte Biosciences Inc (FBRX) - Forte Biosciences, Inc. Announces Third Quarter 2022 Results and Provides Business Update.
Forte Biosciences Inc - Ended Q3 of 2022 With Approximately $44.0 Million in Cash and Cash Equivalents.
Forte Biosciences Inc - Qtrly Net Loss per Share - Basic and Diluted $0.18.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.16

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.